• Trade
  • Markets
  • Copy
  • Contests
  • News
  • 24/7
  • Calendar
  • Q&A
  • Chats
Trending
Screeners
SYMBOL
LAST
BID
ASK
HIGH
LOW
NET CHG.
%CHG.
SPREAD
SPX
S&P 500 Index
6867.27
6867.27
6867.27
6895.79
6862.88
+10.15
+ 0.15%
--
DJI
Dow Jones Industrial Average
47930.63
47930.63
47930.63
48133.54
47873.62
+79.70
+ 0.17%
--
IXIC
NASDAQ Composite Index
23543.34
23543.34
23543.34
23680.03
23506.00
+38.22
+ 0.16%
--
USDX
US Dollar Index
98.990
99.070
98.990
99.060
98.740
+0.010
+ 0.01%
--
EURUSD
Euro / US Dollar
1.16356
1.16363
1.16356
1.16715
1.16277
-0.00089
-0.08%
--
GBPUSD
Pound Sterling / US Dollar
1.33224
1.33232
1.33224
1.33622
1.33159
-0.00047
-0.04%
--
XAUUSD
Gold / US Dollar
4215.05
4215.46
4215.05
4259.16
4194.54
+7.88
+ 0.19%
--
WTI
Light Sweet Crude Oil
60.013
60.043
60.013
60.236
59.187
+0.630
+ 1.06%
--

Community Accounts

Signal Accounts
--
Profit Accounts
--
Loss Accounts
--
View More

Become a signal provider

Sell trading signals to earn additional income

View More

Guide to Copy Trading

Get started with ease and confidence

View More

Signal Accounts for Members

All Signal Accounts

Best Return
  • Best Return
  • Best P/L
  • Best MDD
Past 1W
  • Past 1W
  • Past 1M
  • Past 1Y

All Contests

  • All
  • Trump Updates
  • Recommend
  • Stocks
  • Cryptocurrencies
  • Central Banks
  • Featured News
Top News Only
Share

Cnn Brasil: Brazil Ex-President Bolsonaro Signals Support For Senator Flavio Bolsonaro As Presidential Candidate Next Year

Share

[German 10-year Bond Yield Rises By About 3 Basis Points, Bringing The Weekly Gain To 11 Basis Points] At The Close Of European Trading On Friday (December 5), The Yield On 10-year German Government Bonds Rose 2.8 Basis Points To 2.798%, Continuing Its Upward Trend Since The US Stock Market Opened At 22:30 Beijing Time, Bringing The Weekly Gain To 11.0 Basis Points, Maintaining An Overall Upward Trend. The Yield On 2-year German Bonds Rose 2.1 Basis Points To 2.095%, Breaking Its Previous Low And Stabilizing Position Before The US Stock Market Opened, And Continued To Rise, Bringing The Weekly Gain To 6.6 Basis Points; The Yield On 30-year German Bonds Rose 2.6 Basis Points To 3.430%, Bringing The Weekly Gain To 10.4 Basis Points. The Spread Between The 2-year And 10-year German Bond Yields Rose 0.614 Basis Points To +70.104 Basis Points, Bringing The Weekly Gain To 4.317 Basis Points

Share

French Energy Minister: Request For State Aid Approval For EDF's Six Nuclear Reactor Projects Has Been Sent To Brussels

Share

Congo Orders Cobalt Exporters To Pre-Pay 10% Royalty Within 48 Hours Under New Export Rules, Government Circular Seen By Reuters Shows

Share

US Court Says Trump Can Remove Democrats From Two Federal Labor Boards

Share

In The Past 24 Hours, The Marketvector Digital Asset 100 Small Cap Index Fell 6.62%, Temporarily Reporting 4066.13 Points. The Overall Trend Continued To Decline, And The Decline Accelerated At 00:00 Beijing Time

Share

MSCI Nordic Countries Index Rose 0.5% To 358.24 Points, A New Closing High Since November 13, With A Cumulative Gain Of Over 0.66% This Week. Among The Ten Sectors, The Nordic Industrials Sector Saw The Largest Increase. Neste Oyj Rose 5.4%, Leading The Pack Among Nordic Stocks

Share

Brazil's Petrobras Could Start Production At New Tartaruga Verde Well In Two Years

Share

US President Trump: We Get Along Very Well With Canada And Mexico

Share

Trump: Have Meeting Set Up For After Event, Will Discuss Trade

Share

Canadian Prime Minister Mark Carney Met With Mexican President Jacinda Sinbaum And US President Donald Trump

Share

Trump: Working With Canada And Mexico

Share

Euro Down 0.14% At $1.1629

Share

USA Dollar Index At Session High, Last Up 0.02% At 99.08

Share

Dollar/Yen Up 0.15% At 155.355

Share

Germany's DAX 30 Index Closed Up 0.77% At 24,062.60 Points, Up About 1% For The Week. France's Stock Index Closed Down 0.05%, Italy's Stock Index Closed Down 0.04% And Its Banking Index Fell 0.34%, And The UK's Stock Index Closed Down 0.36%

Share

The STOXX Europe 600 Index Closed Up 0.05% At 579.11 Points, Up Approximately 0.5% For The Week. The Eurozone STOXX 50 Index Closed Up 0.20% At 5729.54 Points, Up Approximately 1.1% For The Week. The FTSE Eurotop 300 Index Closed Up 0.03% At 2307.86 Points

Share

Trump Says He Might Meet With President Of Mexico At Fifa Meeting

Share

Brazil's Real Weakens 2% Versus USA Dollar, To 5.42 Per Greenback In Spot Trading

Share

Europe's STOXX Index Up 0.1%, Euro Zone Blue Chips Index Up 0.1%

TIME
ACT
FCST
PREV
U.K. Halifax House Price Index YoY (SA) (Nov)

A:--

F: --

P: --

France Current Account (Not SA) (Oct)

A:--

F: --

P: --

France Trade Balance (SA) (Oct)

A:--

F: --

P: --

France Industrial Output MoM (SA) (Oct)

A:--

F: --

P: --

Italy Retail Sales MoM (SA) (Oct)

A:--

F: --

P: --

Euro Zone Employment YoY (SA) (Q3)

A:--

F: --

P: --

Euro Zone GDP Final YoY (Q3)

A:--

F: --

P: --

Euro Zone GDP Final QoQ (Q3)

A:--

F: --

P: --

Euro Zone Employment Final QoQ (SA) (Q3)

A:--

F: --

P: --

Euro Zone Employment Final (SA) (Q3)

A:--

F: --

P: --
Brazil PPI MoM (Oct)

A:--

F: --

P: --

Mexico Consumer Confidence Index (Nov)

A:--

F: --

P: --

Canada Unemployment Rate (SA) (Nov)

A:--

F: --

P: --

Canada Labor Force Participation Rate (SA) (Nov)

A:--

F: --

P: --

Canada Employment (SA) (Nov)

A:--

F: --

P: --

Canada Part-Time Employment (SA) (Nov)

A:--

F: --

P: --

Canada Full-time Employment (SA) (Nov)

A:--

F: --

P: --

U.S. Personal Income MoM (Sept)

A:--

F: --

P: --

U.S. PCE Price Index YoY (SA) (Sept)

A:--

F: --

P: --

U.S. PCE Price Index MoM (Sept)

A:--

F: --

P: --

U.S. Personal Outlays MoM (SA) (Sept)

A:--

F: --

P: --

U.S. Core PCE Price Index MoM (Sept)

A:--

F: --

P: --

U.S. Core PCE Price Index YoY (Sept)

A:--

F: --

P: --

U.S. UMich 5-Year-Ahead Inflation Expectations Prelim YoY (Dec)

A:--

F: --

P: --

U.S. Real Personal Consumption Expenditures MoM (Sept)

A:--

F: --

P: --

U.S. 5-10 Year-Ahead Inflation Expectations (Dec)

A:--

F: --

P: --

U.S. UMich Current Economic Conditions Index Prelim (Dec)

A:--

F: --

P: --

U.S. UMich Consumer Sentiment Index Prelim (Dec)

A:--

F: --

P: --

U.S. UMich 1-Year-Ahead Inflation Expectations Prelim (Dec)

A:--

F: --

P: --

U.S. UMich Consumer Expectations Index Prelim (Dec)

A:--

F: --

P: --

U.S. Weekly Total Rig Count

--

F: --

P: --

U.S. Weekly Total Oil Rig Count

--

F: --

P: --

U.S. Consumer Credit (SA) (Oct)

--

F: --

P: --

China, Mainland Foreign Exchange Reserves (Nov)

--

F: --

P: --

China, Mainland Exports YoY (USD) (Nov)

--

F: --

P: --

China, Mainland Imports YoY (CNH) (Nov)

--

F: --

P: --

China, Mainland Imports YoY (USD) (Nov)

--

F: --

P: --

China, Mainland Imports (CNH) (Nov)

--

F: --

P: --

China, Mainland Trade Balance (CNH) (Nov)

--

F: --

P: --

China, Mainland Exports (Nov)

--

F: --

P: --

Japan Wages MoM (Oct)

--

F: --

P: --

Japan Trade Balance (Oct)

--

F: --

P: --

Japan Nominal GDP Revised QoQ (Q3)

--

F: --

P: --

Japan Trade Balance (Customs Data) (SA) (Oct)

--

F: --

P: --

Japan GDP Annualized QoQ Revised (Q3)

--

F: --

P: --
China, Mainland Exports YoY (CNH) (Nov)

--

F: --

P: --

China, Mainland Trade Balance (USD) (Nov)

--

F: --

P: --

Germany Industrial Output MoM (SA) (Oct)

--

F: --

P: --

Euro Zone Sentix Investor Confidence Index (Dec)

--

F: --

P: --

Canada Leading Index MoM (Nov)

--

F: --

P: --

Canada National Economic Confidence Index

--

F: --

P: --

U.S. Dallas Fed PCE Price Index YoY (Sept)

--

F: --

P: --

U.S. 3-Year Note Auction Yield

--

F: --

P: --

U.K. BRC Overall Retail Sales YoY (Nov)

--

F: --

P: --

U.K. BRC Like-For-Like Retail Sales YoY (Nov)

--

F: --

P: --

Australia Overnight (Borrowing) Key Rate

--

F: --

P: --

RBA Rate Statement
RBA Press Conference
Germany Exports MoM (SA) (Oct)

--

F: --

P: --

U.S. NFIB Small Business Optimism Index (SA) (Nov)

--

F: --

P: --

Mexico Core CPI YoY (Nov)

--

F: --

P: --

Q&A with Experts
    • All
    • Chatrooms
    • Groups
    • Friends
    Connecting
    .
    .
    .
    Type here...
    Add Symbol or Code

      No matching data

      All
      Trump Updates
      Recommend
      Stocks
      Cryptocurrencies
      Central Banks
      Featured News
      • All
      • Russia-Ukraine Conflict
      • Middle East Flashpoint
      • All
      • Russia-Ukraine Conflict
      • Middle East Flashpoint
      Search
      Products

      Charts Free Forever

      Chats Q&A with Experts
      Screeners Economic Calendar Data Tools
      Membership Features
      Data Warehouse Market Trends Institutional Data Policy Rates Macro

      Market Trends

      Market Sentiment Order Book Forex Correlations

      Top Indicators

      Charts Free Forever
      Markets

      News

      News Analysis 24/7 Columns Education
      From Institutions From Analysts
      Topics Columnists

      Latest Views

      Latest Views

      Trending Topics

      Top Columnists

      Latest Update

      Signals

      Copy Rankings Latest Signals Become a signal provider AI Rating
      Contests
      Brokers

      Overview Brokers Assessment Rankings Regulators News Claims
      Broker listing Forex Brokers Comparison Tool Live Spread Comparison Scam
      Q&A Complaint Scam Alert Videos Tips to Detect Scam
      More

      Business
      Events
      Careers About Us Advertising Help Center

      White Label

      Data API

      Web Plug-ins

      Affiliate Program

      Awards Institution Evaluation IB Seminar Salon Event Exhibition
      Vietnam Thailand Singapore Dubai
      Fans Party Investment Sharing Session
      FastBull Summit BrokersView Expo
      Recent Searches
        Top Searches
          Markets
          News
          Analysis
          User
          24/7
          Economic Calendar
          Education
          Data
          • Names
          • Latest
          • Prev

          View All

          No data

          Scan to Download

          Faster Charts, Chat Faster!

          Download App
          English
          • English
          • Español
          • العربية
          • Bahasa Indonesia
          • Bahasa Melayu
          • Tiếng Việt
          • ภาษาไทย
          • Français
          • Italiano
          • Türkçe
          • Русский язык
          • 简中
          • 繁中
          Open Account
          Search
          Products
          Charts Free Forever
          Markets
          News
          Signals

          Copy Rankings Latest Signals Become a signal provider AI Rating
          Contests
          Brokers

          Overview Brokers Assessment Rankings Regulators News Claims
          Broker listing Forex Brokers Comparison Tool Live Spread Comparison Scam
          Q&A Complaint Scam Alert Videos Tips to Detect Scam
          More

          Business
          Events
          Careers About Us Advertising Help Center

          White Label

          Data API

          Web Plug-ins

          Affiliate Program

          Awards Institution Evaluation IB Seminar Salon Event Exhibition
          Vietnam Thailand Singapore Dubai
          Fans Party Investment Sharing Session
          FastBull Summit BrokersView Expo

          Reg - Trium Capital Llp Avadel Pharma Plc - Form 8.3 - Avadel Pharmaceuticals Plc

          Reuters
          Avadel Pharmaceuticals
          -0.02%
          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          REG - BlackRock Group Avadel Pharma plc - Form 8.3 - Avadel Pharmaceuticals plc

          London Stock Exchange
          Avadel Pharmaceuticals
          -0.02%
          Blackrock
          +0.06%
          RNS Number : 4692K BlackRock Group 05 December 2025  

          FORM 8.3

          IRISH TAKEOVER PANEL

          OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

          RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

          1.             KEY INFORMATION

          (a)   Full name of discloser

          BlackRock, Inc.

          (b)   Owner or controller of interests and short positions disclosed, if different from 1(a)

          The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

          N/A

          (c)   Name of offeror/offeree in relation to whose relevant securities this form relates

          Use a separate form for each offeror/offeree

          Avadel Pharmaceuticals plc

          (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

          (e)   Date position held/dealing undertaken

          For an opening position disclosure, state the latest practicable date prior to the disclosure

          04 December 2025

          (f)    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

          If it is a cash offer or possible cash offer, state "N/A"

          N/A

          2.             INTERESTS AND SHORT POSITIONS

          If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

          Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

          (Note 2)

          Class of relevant security

          (Note 3)

          $0.01 ordinary shares

          Interests

          Short positions

          Number

          %

          Number

          %

          (1)   Relevant securities owned and/or controlled

          6,887,394

          7.01%

          2,934

          0.00%

          (2)   Cash-settled derivatives

          0

          0.00%

          4,268

          0.00%

          (3)   Stock-settled derivatives (including options) and agreements to purchase/ sell

          0

          0.00%

          0

          0.00%

          Total

          6,887,394

          7.01%

          7,202

          0.00%

          All interests and all short positions should be disclosed.

          Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

          3.             DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

          Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

          The currency of all prices and other monetary amounts should be stated.

          (a)           Purchases and sales

          Class of relevant security

          Purchase/sale

          Number of securities

          Price per unit

          (Note 5)

          $0.01 ordinary shares

          Purchase

          3,200

          USD 21.3550

          $0.01 ordinary shares

          Sale

          135

          USD 21.3550

          (b)           Cash-settled derivative transactions

          • Class of relevant security

          • Product

            description

            e.g. CFD

          • Nature of dealing

            e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

          • Number of

            reference

            securities

            (Note 6)

          • Price

            per unit

            (Note 5)

          (c)           Stock-settled derivative transactions (including options)

          (i)            Writing, selling, purchasing or varying

          • Class of relevant security

          • Product

            description e.g. call

            option

          • Writing, purchasing, selling, varying

            etc.

          • Number of

            securities to which option relates (Note 6)

          • Exercise

            price per

            unit

          • Type

            e.g. American,

            European etc.

          • Expiry

            date

          • Option money

            paid/

            received per unit

          (ii)           Exercise

          • Class of relevant security

          • Product description

            e.g. call option

          • Exercising/

            exercised against

          • Number of securities

          • Exercise price per unit (Note 5)

          (d)           Other dealings (including transactions in respect of new securities) (Note 3)

          Class of relevant

          security

          Nature of dealing

          e.g. subscription, conversion, exercise

          Details

          Price per unit (if applicable)

          (Note 5)

          $0.01 ordinary shares

          Return of Stock on Loan

          76,800

          N/A

          $0.01 ordinary shares

          Transfer out of Shares

          15,620

          N/A

          4.             OTHER INFORMATION

          (a)           Indemnity and other dealing arrangements

          Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

          Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

          (b)           Agreements, arrangements or understandings relating to options or derivatives

          Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

          (c)           Attachments

          • Is a Supplemental Form 8 attached?

          • NO

          Date of disclosure

          05 December 2025

          Contact name

          Jana Blumenstein

          Telephone number

          +44 20 7743 3650

          Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

          NOTES ON FORM 8.3

          1.             See the definition of "connected fund manager" in Rule 2.2 of Part A of the Rules.

          2.             See the definition of "interest in a relevant security" in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules.

          3.             See the definition of "relevant securities" in Rule 2.1 of Part A of the Rules.

          4.             See the definition of "dealing" in Rule 2.1 of Part A of the Rules.

          5.             If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.

          6.             See Rule 2.5(d) of Part A of the Rules.

          7.             If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.

          For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

          References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

          This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

          RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  ITPPKPBPKBDDFBK

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          REG - TIG Advisors, LLC Avadel Pharma plc - Form 8.3 - Avadel Pharmaceuticals plc

          London Stock Exchange
          Avadel Pharmaceuticals
          -0.02%
          RNS Number : 5168K TIG Advisors, LLC 05 December 2025  

          FORM 8.3

          IRISH TAKEOVER PANEL

          OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

          RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

          1.             KEY INFORMATION

          (a)   Full name of discloser

          TIG Advisors, LLC

          (b)   Owner or controller of interests and short positions disclosed, if different from 1(a)

          The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

          (c)   Name of offeror/offeree in relation to whose relevant securities this form relates

          Use a separate form for each offeror/offeree

          Avadel Pharmaceuticals plc

          (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

          (e)   Date position held/dealing undertaken

          For an opening position disclosure, state the latest practicable date prior to the disclosure

          4 December 2025

          (f)    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

          If it is a cash offer or possible cash offer, state "N/A"

          N/A

          2.             INTERESTS AND SHORT POSITIONS

          If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

          Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

          (Note 2)

          Class of relevant security

          (Note 3)

          US$0.01 ordinary shares

          Interests

          Short positions

          Number

          %

          Number

          %

          (1)   Relevant securities owned and/or controlled

          3,865,235

          3.94%

          (2)   Cash-settled derivatives

          (3)   Stock-settled derivatives (including options) and agreements to purchase/ sell

          Total

          3,865,235

          3.94%

          All interests and all short positions should be disclosed.

          Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

          3.             DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

          Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

          The currency of all prices and other monetary amounts should be stated.

          (a)           Purchases and sales

          Class of relevant

          security

          Purchase/sale

          Number of

          securities

          Price per unit

          (Note 5)

           $0.01 ordinary shares

          Purchase

          72,302

          USD 21.31

           $0.01 ordinary shares

          Purchase

          64,789

          USD 21.34

          (b)           Cash-settled derivative transactions

          • Class of

            relevant

            security

          • Product

            description

            e.g. CFD

          • Nature of dealing

            e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

          • Number of

            reference

            securities

            (Note 6)

          • Price

            per unit

            (Note 5)

          (c)           Stock-settled derivative transactions (including options)

          (i)            Writing, selling, purchasing or varying

          • Class of

            relevant

            security

          • Product

            description e.g. call

            option

          • Writing, purchasing, selling, varying

            etc.

          • Number

            of

            securities

            to which

            option

            relates

            (Note 6)

          • Exercise

            price per

            unit

          • Type

            e.g.

            American,

            European

            etc.

          • Expiry

            date

          • Option

            money

            paid/

            received per unit

          (ii)           Exercise

          • Class of

            relevant

            security

          • Product

            description

            e.g. call

            option

          • Exercising/

            exercised

            against

          • Number of

            securities

          • Exercise

            price per

            unit

            (Note 5)

          (d)           Other dealings (including transactions in respect of new securities) (Note 3)

          • Class of

            relevant

            security

          • Nature of dealing

            e.g. subscription,

            conversion, exercise

          • Details

          • Price per unit (if

            applicable)

            (Note 5)

          4.             OTHER INFORMATION

          (a)           Indemnity and other dealing arrangements

          Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

          Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

          (b)           Agreements, arrangements or understandings relating to options or derivatives

          Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

          (c)           Attachments

          • Is a Supplemental Form 8 attached?

          • NO

          Date of disclosure

          5 December 2025

          Contact name

          Cordelia Kim

          Telephone number

          +1 212-396-8669

          Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

          NOTES ON FORM 8.3

          1.             See the definition of "connected fund manager" in Rule 2.2 of Part A of the Rules.

          2.             See the definition of "interest in a relevant security" in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules.

          3.             See the definition of "relevant securities" in Rule 2.1 of Part A of the Rules.

          4.             See the definition of "dealing" in Rule 2.1 of Part A of the Rules.

          5.             If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.

          6.             See Rule 2.5(d) of Part A of the Rules.

          7.             If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.

          For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

          References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

          This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

          RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  ITPFLFLEFRLEIIE

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Reg - Goldman Sachs (Ept) Avadel Pharma Plc - From 38.5 Billion - Avadel Pharmaceuticals Plc

          Reuters
          Avadel Pharmaceuticals
          -0.02%
          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          REG - Trium Capital LLP Avadel Pharma plc - Form 8.3 - AVADEL PHARMACEUTICALS PLC

          London Stock Exchange
          Avadel Pharmaceuticals
          -0.02%
          RNS Number : 5160K Trium Capital LLP 05 December 2025  

          FORM 8.3

          IRISH TAKEOVER PANEL

          OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

          RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

          1.             KEY INFORMATION

          (a)   Full name of discloser

          Trium Capital LLP

          (b)   Owner or controller of interests and short positions disclosed, if different from 1(a)

          The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

          (c)   Name of offeror/offeree in relation to whose relevant securities this form relates

          Use a separate form for each offeror/offeree

          AVADEL PHARMACEUTICALS PLC

          (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

          (e)   Date position held/dealing undertaken

          For an opening position disclosure, state the latest practicable date prior to the disclosure

          04/12/2025

          (f)    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

          If it is a cash offer or possible cash offer, state "N/A"

           N/A

          :

          2.             INTERESTS AND SHORT POSITIONS

          If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

          Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

          (Note 2)

          Class of relevant security

          (Note 3)

          USD 0.01

          Interests

          Short positions

          Number

          %

          Number

          %

          (1)   Relevant securities owned and/or controlled

          1,118,314

          1.14

          (2)   Cash-settled derivatives

          21,266

          0.02

          (3)   Stock-settled derivatives (including options) and agreements to purchase/ sell

          Total

          1,139,580

          1.16

          All interests and all short positions should be disclosed.

          Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

          3.             DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

          Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

          The currency of all prices and other monetary amounts should be stated.

          (a)           Purchases and sales

          Class of relevant

          security

          Purchase/sale

          Number of

          securities

          Price per unit

          (Note 5)

           USD 0.01

          Purchase

          41,620

          USD 21.325

          USD 0.01

          Purchase

          61,278

          USD 21.3446

          USD 0.01

          Purchase

          41,621

          USD 21.3485

          USD 0.01

          Purchase

          52,026

          USD 21.35

          (b)           Cash-settled derivative transactions

          Class of

          relevant

          security

          Product

          description

          e.g. CFD

          Nature of dealing

          e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

          Number of

          reference

          securities

          (Note 6)

          Price

          per unit

          (Note 5)

          USD 0.01

          CFD

          Increasing long position

          4,634

          USD 21.325

          USD 0.01

          CFD

          Increasing long position

          5,675

          USD 21.3498

          (c)           Stock-settled derivative transactions (including options)

          (i)            Writing, selling, purchasing or varying

          • Class of

            relevant

            security

          • Product

            description e.g. call

            option

          • Writing, purchasing, selling, varying

            etc.

          • Number

            of

            securities

            to which

            option

            relates

            (Note 6)

          • Exercise

            price per

            unit

          • Type

            e.g.

            American,

            European

            etc.

          • Expiry

            date

          • Option

            money

            paid/

            received per unit

          (ii)           Exercise

          • Class of

            relevant

            security

          • Product

            description

            e.g. call

            option

          • Exercising/

            exercised

            against

          • Number of

            securities

          • Exercise

            price per

            unit

            (Note 5)

          (d)           Other dealings (including transactions in respect of new securities) (Note 3)

          • Class of

            relevant

            security

          • Nature of dealing

            e.g. subscription,

            conversion, exercise

          • Details

          • Price per unit (if

            applicable)

            (Note 5)

          4.             OTHER INFORMATION

          (a)           Indemnity and other dealing arrangements

          • Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

            Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

          • NONE

          (b)           Agreements, arrangements or understandings relating to options or derivatives

          • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

          • NONE

          (c)           Attachments

          • Is a Supplemental Form 8 attached?

          • NO

          Date of disclosure

          05/12/2025

          Contact name

          Andrew Crick

          Telephone number

          +44 (0)20 7073 9269

          Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

          This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

          RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  ITPFLFIEFDLEIIE

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          REG - Citadel Group Avadel Pharma plc - Form 8.3 - Avadel Pharmaceuticals plc

          London Stock Exchange
          Avadel Pharmaceuticals
          -0.02%
          RNS Number : 4859K Citadel Group 05 December 2025  

          Ap27

          FORM 8.3

          IRISH TAKEOVER PANEL

          OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

          RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

          1.             KEY INFORMATION

          (a)   Full name of discloser

          Citadel Group

          (b)   Owner or controller of interests and short positions disclosed, if different from 1(a)

          The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

          N/A

          (c)   Name of offeror/offeree in relation to whose relevant securities this form relates

          Use a separate form for each offeror/offeree

          AVADEL PHARMACEUTICALS PLC

          (d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

          N/A

          (e)   Date position held/dealing undertaken

          For an opening position disclosure, state the latest practicable date prior to the disclosure

          4 December 2025

          (f)    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

          If it is a cash offer or possible cash offer, state "N/A"

          N/A

          2.             INTERESTS AND SHORT POSITIONS

          If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

          Ap28

          Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

          (Note 2)

          Class of relevant security

          (Note 3)

          Common Stock ISIN IE00BDGMC594

          $0.01 ordinary shares

          Interests

          Short positions

          Number

          %

          Number

          %

          (1)   Relevant securities owned and/or controlled

          987,476

          1.00

          245,168

          0.24

          (2)   Cash-settled derivatives

          0

          0.00

          0

          0.00

          (3)   Stock-settled derivatives (including options) and agreements to purchase/ sell

          195,400

          0.19

          791,800

          0.80

          Total

          1,182,876

          1.20

          1,036,968

          1.05

          All interests and all short positions should be disclosed.

          Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

          3.             DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

          Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

          The currency of all prices and other monetary amounts should be stated.

          (a)           Purchases and sales

          Class of relevant

          security

          Purchase/sale

          Number of

          securities

          Price per unit

          (Note 5)

           Common

          Buy Transaction

          1

          21.2200 USD

           Common

          Buy Transaction

          700

          21.3200 USD

           Common

          Buy Transaction

          608

          21.3204 USD

           Common

          Buy Transaction

          103

          21.3209 USD

           Common

          Buy Transaction

          100

          21.3225 USD

           Common

          Buy Transaction

          1,467

          21.3242 USD

           Common

          Buy Transaction

          2,284

          21.3250 USD

           Common

          Buy Transaction

          1,419

          21.3250 USD

           Common

          Buy Transaction

          384

          21.3258 USD

           Common

          Buy Transaction

          5,016

          21.3298 USD

           Common

          Buy Transaction

          35,507

          21.3300 USD

           Common

          Buy Transaction

          28

          21.3336 USD

           Common

          Buy Transaction

          233

          21.3342 USD

           Common

          Buy Transaction

          120

          21.3350 USD

           Common

          Buy Transaction

          723

          21.3400 USD

           Common

          Buy Transaction

          825

          21.3403 USD

           Common

          Buy Transaction

          760

          21.3409 USD

           Common

          Buy Transaction

          1,482

          21.3411 USD

           Common

          Buy Transaction

          114

          21.3422 USD

           Common

          Buy Transaction

          15

          21.3427 USD

           Common

          Buy Transaction

          1,240

          21.3451 USD

           Common

          Buy Transaction

          1,347

          21.3453 USD

           Common

          Buy Transaction

          1,700

          21.3453 USD

           Common

          Buy Transaction

          6,779

          21.3460 USD

           Common

          Buy Transaction

          90

          21.3484 USD

           Common

          Buy Transaction

          62

          21.3487 USD

           Common

          Buy Transaction

          535

          21.3500 USD

           Common

          Buy Transaction

          2,535

          21.3504 USD

           Common

          Buy Transaction

          911

          21.3506 USD

           Common

          Buy Transaction

          70

          21.3507 USD

           Common

          Buy Transaction

          912

          21.3517 USD

           Common

          Buy Transaction

          833

          21.3526 USD

           Common

          Buy Transaction

          3,068

          21.3529 USD

           Common

          Buy Transaction

          30

          21.3533 USD

           Common

          Buy Transaction

          647

          21.3535 USD

           Common

          Buy Transaction

          81

          21.3537 USD

           Common

          Buy Transaction

          1,200

          21.3538 USD

           Common

          Buy Transaction

          412

          21.3538 USD

           Common

          Buy Transaction

          433

          21.3539 USD

           Common

          Buy Transaction

          533

          21.3541 USD

           Common

          Buy Transaction

          3,773

          21.3550 USD

           Common

          Buy Transaction

          3,065

          21.3550 USD

           Common

          Buy Transaction

          1,373

          21.3550 USD

           Common

          Buy Transaction

          297

          21.3550 USD

           Common

          Buy Transaction

          87

          21.3551 USD

           Common

          Buy Transaction

          17

          21.3553 USD

           Common

          Buy Transaction

          239

          21.3554 USD

           Common

          Buy Transaction

          1,369

          21.3555 USD

           Common

          Buy Transaction

          10

          21.3560 USD

           Common

          Buy Transaction

          1,000

          21.3561 USD

           Common

          Buy Transaction

          6,127

          21.3561 USD

           Common

          Buy Transaction

          665

          21.3565 USD

           Common

          Buy Transaction

          3

          21.3567 USD

           Common

          Buy Transaction

          2,300

          21.3570 USD

           Common

          Buy Transaction

          30

          21.3570 USD

           Common

          Buy Transaction

          27

          21.3570 USD

           Common

          Buy Transaction

          723

          21.3571 USD

           Common

          Buy Transaction

          400

          21.3575 USD

           Common

          Buy Transaction

          2,500

          21.3576 USD

           Common

          Buy Transaction

          112

          21.3579 USD

           Common

          Buy Transaction

          431

          21.3582 USD

           Common

          Buy Transaction

          200

          21.3590 USD

           Common

          Buy Transaction

          311

          21.3593 USD

           Common

          Buy Transaction

          3,012

          21.3593 USD

           Common

          Buy Transaction

          330

          21.3597 USD

           Common

          Buy Transaction

          2,788

          21.3598 USD

           Common

          Buy Transaction

          54,526

          21.3600 USD

           Common

          Buy Transaction

          1,163

          21.3619 USD

           Common

          Buy Transaction

          18

          21.3622 USD

           Common

          Buy Transaction

          9

          21.3633 USD

           Common

          Buy Transaction

          1,301

          21.3700 USD

           Common

          Buy Transaction

          371

          21.3757 USD

           Common

          Buy Transaction

          1,039

          21.3800 USD

           Common

          Sell Transaction

          200

          21.3200 USD

           Common

          Sell Transaction

          4,600

          21.3243 USD

           Common

          Sell Transaction

          1,200

          21.3250 USD

           Common

          Sell Transaction

          9,454

          21.3293 USD

           Common

          Sell Transaction

          6,500

          21.3299 USD

           Common

          Sell Transaction

          800

          21.3300 USD

           Common

          Sell Transaction

          110

          21.3318 USD

           Common

          Sell Transaction

          5,000

          21.3350 USD

           Common

          Sell Transaction

          226

          21.3400 USD

           Common

          Sell Transaction

          401

          21.3400 USD

           Common

          Sell Transaction

          855

          21.3431 USD

           Common

          Sell Transaction

          21

          21.3433 USD

           Common

          Sell Transaction

          2,508

          21.3450 USD

           Common

          Sell Transaction

          1,231

          21.3452 USD

           Common

          Sell Transaction

          1,627

          21.3458 USD

           Common

          Sell Transaction

          310

          21.3471 USD

           Common

          Sell Transaction

          800

          21.3475 USD

           Common

          Sell Transaction

          700

          21.3479 USD

           Common

          Sell Transaction

          500

          21.3480 USD

           Common

          Sell Transaction

          2,737

          21.3487 USD

           Common

          Sell Transaction

          2,548

          21.3492 USD

           Common

          Sell Transaction

          1,016

          21.3500 USD

           Common

          Sell Transaction

          120

          21.3507 USD

           Common

          Sell Transaction

          1,230

          21.3511 USD

           Common

          Sell Transaction

          644

          21.3522 USD

           Common

          Sell Transaction

          725

          21.3525 USD

           Common

          Sell Transaction

          743

          21.3533 USD

           Common

          Sell Transaction

          296

          21.3535 USD

           Common

          Sell Transaction

          22

          21.3536 USD

           Common

          Sell Transaction

          56

          21.3545 USD

           Common

          Sell Transaction

          22,387

          21.3550 USD

           Common

          Sell Transaction

          3,065

          21.3550 USD

           Common

          Sell Transaction

          1,267

          21.3550 USD

           Common

          Sell Transaction

          407

          21.3550 USD

           Common

          Sell Transaction

          125

          21.3550 USD

           Common

          Sell Transaction

          87

          21.3551 USD

           Common

          Sell Transaction

          79

          21.3551 USD

           Common

          Sell Transaction

          2,157

          21.3554 USD

           Common

          Sell Transaction

          203

          21.3557 USD

           Common

          Sell Transaction

          25,000

          21.3574 USD

           Common

          Sell Transaction

          401

          21.3575 USD

           Common

          Sell Transaction

          41

          21.3583 USD

           Common

          Sell Transaction

          104

          21.3588 USD

           Common

          Sell Transaction

          37,948

          21.3600 USD

           Common

          Sell Transaction

          530

          21.3613 USD

           Common

          Sell Transaction

          400

          21.3650 USD

           Common

          Sell Transaction

          171

          21.3673 USD

           Common

          Sell Transaction

          1,200

          21.3700 USD

           Common

          Sell Transaction

          501

          21.3800 USD

           Common

          Sell Transaction

          1

          21.4900 USD

          Ap29

          (b)           Cash-settled derivative transactions

          • Class of

            relevant

            security

          • Product

            description

            e.g. CFD

          • Nature of dealing

            e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

          • Number of

            reference

            securities

            (Note 6)

          • Price

            per unit

            (Note 5)

          (c)           Stock-settled derivative transactions (including options)

          (i)            Writing, selling, purchasing or varying

          Class of

          relevant

          security

          Product

          description e.g. call

          option

          Writing, purchasing, selling, varying

          etc.

          Number

          of

          securities

          to which

          option

          relates

          (Note 6)

          Exercise

          price per

          unit

          Type

          e.g.

          American,

          European

          etc.

          Expiry

          date

          Option

          money

          paid/

          received per unit

          Common

          Put Option

          Buy Transaction

          100

          20.0000 USD

          American

          2026-03-20

          0.0700 USD

          Common

          Call Option

          Buy Transaction

          4,800

          20.0000 USD

          American

          2025-12-19

          1.3500 USD

          Common

          Call Option

          Buy Transaction

          200

          15.0000 USD

          American

          2026-01-16

          6.3800 USD

          (ii)           Exercise

          • Class of

            relevant

            security

          • Product

            description

            e.g. call

            option

          • Exercising/

            exercised

            against

          • Number of

            securities

          • Exercise

            price per

            unit

            (Note 5)

          (d)           Other dealings (including transactions in respect of new securities) (Note 3)

          • Class of

            relevant

            security

          • Nature of dealing

            e.g. subscription,

            conversion, exercise

          • Details

          • Price per unit (if

            applicable)

            (Note 5)

          Ap30

          4.             OTHER INFORMATION

          (a)           Indemnity and other dealing arrangements

          • Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

            Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

          • None

          (b)           Agreements, arrangements or understandings relating to options or derivatives

          • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

          • None

          (c)           Attachments

          • Is a Supplemental Form 8 attached?

          • YES

          Date of disclosure

          5 December 2025

          Contact name

          Paula Santos

          Telephone number

          020 7645 9700

          Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

          Ap32

          SUPPLEMENTAL FORM 8

          IRISH TAKEOVER PANEL

          DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

          RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

          TAKEOVER RULES, 2022

          DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

          OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

          RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

          1.             KEY INFORMATION

          Full name of person making

          disclosure:

          Citadel Group

          Name of offeror/offeree in relation

          to whose relevant securities the

          disclosure relates:

          AVADEL PHARMACEUTICALS PLC

          2.             STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

          Class of

          relevant

          security

          Product

          description

          e.g. call

          option

          Written or

          purchased

          Number of

          securities to

          which option

          or derivative

          relates

          Exercise

          price

          per unit

          Type

          e.g.

          American,

          European

          etc.

          Expiry

          date

          Common

          Call Option

          Purchased

          4,200

          17.5 USD

          American

          16/01/2026

          Common

          Put Option

          Purchased

          -3,100

          12.5 USD

          American

          20/03/2026

          Common

          Call Option

          Purchased

          0

          5.0 USD

          American

          16/01/2026

          Common

          Call Option

          Purchased

          24,200

          22.5 USD

          American

          20/03/2026

          Common

          Call Option

          Purchased

          5,100

          15.0 USD

          American

          15/01/2027

          Common

          Put Option

          Purchased

          -100

          7.5 USD

          American

          20/03/2026

          Common

          Put Option

          Purchased

          -1,000

          17.5 USD

          American

          18/06/2026

          Common

          Put Option

          Purchased

          -200

          17.5 USD

          American

          20/03/2026

          Common

          Put Option

          Purchased

          -60,700

          15.0 USD

          American

          16/01/2026

          Common

          Put Option

          Purchased

          -900

          25.0 USD

          American

          20/03/2026

          Common

          Call Option

          Purchased

          900

          7.5 USD

          American

          19/12/2025

          Common

          Call Option

          Purchased

          2,200

          20.0 USD

          American

          18/06/2026

          Common

          Put Option

          Purchased

          -2,900

          7.5 USD

          American

          19/12/2025

          Common

          Put Option

          Purchased

          -100

          20.0 USD

          American

          18/06/2026

          Common

          Call Option

          Purchased

          5,600

          12.5 USD

          American

          15/01/2027

          Common

          Put Option

          Purchased

          -4,700

          15.0 USD

          American

          19/12/2025

          Common

          Put Option

          Purchased

          -3,800

          15.0 USD

          American

          20/03/2026

          Common

          Put Option

          Purchased

          0

          12.5 USD

          American

          15/01/2027

          Common

          Call Option

          Purchased

          33,900

          20.0 USD

          American

          19/12/2025

          Common

          Call Option

          Purchased

          3,000

          25.0 USD

          American

          15/01/2027

          Common

          Put Option

          Purchased

          -100

          15.0 USD

          American

          15/01/2027

          Common

          Call Option

          Purchased

          0

          25.0 USD

          American

          20/03/2026

          Common

          Call Option

          Purchased

          5,100

          22.5 USD

          American

          15/01/2027

          Common

          Put Option

          Purchased

          0

          10.0 USD

          American

          20/03/2026

          Common

          Put Option

          Purchased

          -44,400

          10.0 USD

          American

          16/01/2026

          Common

          Put Option

          Sold

          2,000

          17.5 USD

          American

          19/12/2025

          Common

          Call Option

          Sold

          -1,700

          25.0 USD

          American

          16/01/2026

          Common

          Call Option

          Sold

          -6,800

          25.0 USD

          American

          19/12/2025

          Common

          Call Option

          Sold

          -100

          20.0 USD

          American

          15/01/2027

          Common

          Put Option

          Sold

          8,200

          10.0 USD

          American

          19/12/2025

          Common

          Put Option

          Sold

          59,000

          5.0 USD

          American

          16/01/2026

          Common

          Call Option

          Sold

          -2,100

          12.5 USD

          American

          20/03/2026

          Common

          Call Option

          Sold

          -13,400

          10.0 USD

          American

          15/01/2027

          Common

          Call Option

          Sold

          -5,100

          10.0 USD

          American

          19/12/2025

          Common

          Call Option

          Sold

          -2,600

          30.0 USD

          American

          16/01/2026

          Common

          Call Option

          Sold

          -6,200

          12.5 USD

          American

          19/12/2025

          Common

          Call Option

          Sold

          -100

          35.0 USD

          American

          16/01/2026

          Common

          Call Option

          Sold

          -34,200

          5.0 USD

          American

          15/01/2027

          Common

          Call Option

          Sold

          -9,900

          22.5 USD

          American

          16/01/2026

          Common

          Put Option

          Sold

          4,400

          17.5 USD

          American

          16/01/2026

          Common

          Put Option

          Sold

          24,900

          7.5 USD

          American

          16/01/2026

          Common

          Call Option

          Sold

          -30,000

          15.0 USD

          American

          20/03/2026

          Common

          Put Option

          Sold

          5,500

          12.5 USD

          American

          16/01/2026

          Common

          Call Option

          Sold

          -31,800

          17.5 USD

          American

          19/12/2025

          Common

          Put Option

          Sold

          5,300

          20.0 USD

          American

          19/12/2025

          Common

          Put Option

          Sold

          300

          20.0 USD

          American

          20/03/2026

          Common

          Call Option

          Sold

          -4,800

          17.5 USD

          American

          15/01/2027

          Common

          Put Option

          Sold

          1,600

          12.5 USD

          American

          19/12/2025

          Common

          Call Option

          Sold

          -38,000

          15.0 USD

          American

          19/12/2025

          Common

          Call Option

          Sold

          -10,200

          7.5 USD

          American

          15/01/2027

          Common

          Call Option

          Sold

          -147,800

          15.0 USD

          American

          16/01/2026

          Common

          Call Option

          Sold

          -10,000

          17.5 USD

          American

          20/03/2026

          Common

          Call Option

          Sold

          -46,200

          20.0 USD

          American

          16/01/2026

          Common

          Call Option

          Sold

          -100

          30.0 USD

          American

          19/12/2025

          Common

          Call Option

          Sold

          -182,900

          10.0 USD

          American

          16/01/2026

          Common

          Call Option

          Sold

          -4,900

          22.5 USD

          American

          19/12/2025

          Common

          Call Option

          Sold

          -5,400

          20.0 USD

          American

          20/03/2026

          Common

          Call Option

          Sold

          -65,900

          12.5 USD

          American

          16/01/2026

          Common

          Call Option

          Sold

          -9,600

          7.5 USD

          American

          16/01/2026

          3.             AGREEMENTS TO PURCHASE OR SELL

          Full details should be given so that the nature of the interest or position can be fully understood:

          Ap33

          4.             RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS' AND OTHER EMPLOYEE OPTIONS)

          • Class of relevant security in relation to which subscription right exists:

          • Details, including nature of the rights concerned and relevant percentages:

          It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

          The currency of all prices and other monetary amounts should be stated.

          For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

          References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

          This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

          RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  ITPTABBTMTAMBMA

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          REG - Goldman Sachs (EPT) Avadel Pharma plc - From 38.5b - Avadel Pharmaceuticals plc

          London Stock Exchange
          Avadel Pharmaceuticals
          -0.02%
          Goldman Sachs
          +2.01%
          RNS Number : 5110K GoldmanSachs International 05 December 2025  

           

          FORM 38.5(b)

          IRISH TAKEOVER PANEL

          DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

          DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

          1. KEY INFORMATION

          Name of exempt principal trader

          (GS) GOLDMAN SACHS INTERNATIONAL

          Company dealt in

          AVADEL PHARMACEUTICALS PLC

          Class of relevant security to which the dealings being disclosed relate (Note1)

          USD 0.01 ordinary shares

          Date of dealing

          04 December 2025

          2. INTERESTS AND SHORT POSITIONS

          (a) Interests and short positions (following dealing) in the class of relevant security dealt in  (Note 2)

          Long

          Short

          Number

          (%)

          Number

          (%)

          (1) Relevant securities

          53

          (0.00)

          1,151

          (0.00)

          (2) Derivatives (other than options)

          0

          (0.00)

          0

          (0.00)

          (3) Options and agreements to purchase/sell

          0

          (0.00)

          0

          (0.00)

          Total

          53

          (0.00)

          1,151

          (0.00)

          (b) Interests and short positions in relevant securities of the company, other than the class dealt in  (Note 2)

          Class of relevant security:

          Long

          Short

          Number

          (%)

          Number

          (%)

          (1) Relevant securities

          (2) Derivatives (other than options)

          (3) Options and agreements to purchase/sell

          Total

          3.    DEALINGS (Note 3)

          (a) Purchases and sales

          Purchase/sale

          Number of relevant securities

          Price per unit  (Note 4)

          Purchase (Loan Full Return)

          27

          N/A

          Sale (Loan New)

          27

          N/A

          Purchase (Loan Full Return)

          3

          N/A

          Sale (Loan New)

          3

          N/A

          Purchase (Borrow New)

          53

          N/A

          Sale (Borrow Partial Return)

          27

          N/A

          Purchase (Borrow New)

          30

          N/A

          Sale (Borrow Full Return)

          3

          N/A

          Sale (Borrow Full Return)

          53

          N/A

          Sale (Loan New)

          53

          N/A

          Purchase (Loan Partial Return)

          3

          N/A

          Purchase (Loan Partial Return)

          27

          N/A

          (b) Derivatives transactions (other than options transactions)

          • Product name, e.g. CFD

          • Nature of transaction  (Note 5)

          • Number of relevant securities  (Note 6)

          • Price per unit  (Note 4)

          (c) Options transactions in respect of existing relevant securities

          (i) Writing, selling, purchasing or varying

          • Product name,e.g. call option

          • Writing, selling,  purchasing, varying etc.

          • Number of securities to which the option relates  (Note 7)

          • Exercise price

          • Type, e.g. American, European etc.

          • Expiry date

          • Option money paid/received per unit  (Note 4)

          (ii)            Exercising

          • Product name,e.g. call option

          • Number of securities

          • Exercise price per unit  (Note 4)

          (d)            Other dealings (including transactions in respect of new securities)  (Note 3)

          • Nature of transaction  (Note 7)

          • Details

          • Price per unit (if applicable)  (Note 4)

          4. OTHER INFORMATION

          Agreements, arrangements or understandings relating to options or derivatives

          • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.  If none, this should be stated. 

          • NONE

          Is a Supplemental Form 8 attached? (Note 9)        NO

          Date of disclosure

          05 December 2025

          Contact name

          Papa Lette and Andrzej Szyszka

          Telephone number

          +33(1) 4212 1459 / +48(22) 317 4817

          Name of offeree/offeror with which connected

          AVADEL PHARMACEUTICALS PLC

          Nature of connection (Note 9)

          Advisor to Offeree

          This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

          RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  ITPUPGCGPUPAGCA

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share
          FastBull
          Copyright © 2025 FastBull Ltd

          728 RM B 7/F GEE LOK IND BLDG NO 34 HUNG TO RD KWUN TONG KLN HONG KONG

          TelegramInstagramTwitterfacebooklinkedin
          App Store Google Play Google Play
          Products
          Charts

          Chats

          Q&A with Experts
          Screeners
          Economic Calendar
          Data
          Tools
          Membership
          Features
          Function
          Markets
          Copy Trading
          Latest Signals
          Contests
          News
          Analysis
          24/7
          Columns
          Education
          Company
          Careers
          About Us
          Contact Us
          Advertising
          Help Center
          Feedback
          User Agreement
          Privacy Policy
          Business

          White Label

          Data API

          Web Plug-ins

          Poster Maker

          Affiliate Program

          Risk Disclosure

          The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.

          No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.

          Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.

          Not Logged In

          Log in to access more features

          FastBull Membership

          Not yet

          Purchase

          Become a signal provider
          Help Center
          Customer Service
          Dark Mode
          Price Up/Down Colors

          Log In

          Sign Up

          Position
          Layout
          Fullscreen
          Default to Chart
          The chart page opens by default when you visit fastbull.com